FDA Depoze pou UniQure, Haemophilia B CSL a Terapi jèn Planifye pou bonè 2022

FDA Depoze pou UniQure, Haemophilia B CSL a Terapi jèn Planifye pou bonè 2022

FirstWord Pharma

Imaj

Please enable the javascript to submit this form

Sipòte pa sibvansyon edikasyon bay Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL